Tags

Type your tag names separated by a space and hit enter

Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up.
Surg Obes Relat Dis. 2015 Mar-Apr; 11(2):321-6.SO

Abstract

BACKGROUND

Laparoscopic mini-gastric bypass (LMGB) is an alternative to the laparoscopic Roux-en-Y gastric bypass (LRYGB), which is considered to be the gold standard in the treatment of morbid obesity.

OBJECTIVES

Present 5-year results of 175 patients who had undergone a LMGB between October 2006 and October 2008.

SETTING

University public hospital, France.

METHODS

Complete follow-up was available in 126 of 175 patients (72%) who had LMGB. Mortality, morbidity, weight loss, co-morbidities, and quality of life were assessed. Weight loss was determined as a change in body mass index (BMI) and percent excess BMI loss (%EBMIL). Quality of life in the treatment group was analyzed using the Gastrointestinal Quality of Life Index (GIQLI) and was compared with a retrospectively case matched preoperative control group.

RESULTS

There were no deaths. Thirteen patients (10.3%) developed major complications. Marginal ulcers occurred in 4% of patients. Incapacitating biliary reflux developed in 2 (1.6%) who required conversion into RYGB. Gastric pouch dilation occurred in 4 patients (3.2%) and inadequate weight loss with severe malnutrition in 2 (1.6%). At 5 years, mean BMI was 31±6 kg/m(2) and mean %EBMIL was 71.5%±26.5%. Postoperative GIQLI score of the treatment group was significantly higher than preoperative score of the control group (110.3±17.4 versus 92.5±15.9, P<.001). Social, psychological, and physical functions were increased significantly. No significant differences were found in gastroesophageal reflux or diarrhea symptoms between the 2 groups. Long-term follow-up showed an improvement in all co-morbidities.

CONCLUSIONS

At 5 years, LMGB was safe, effective, and provided interesting quality of life results.

Authors+Show Affiliations

Hôpital Européen Georges Pompidou, Paris, France. Electronic address: matthieu_bruz@yahoo.fr.Hôpital Européen Georges Pompidou, Paris, France.Hôpital Européen Georges Pompidou, Paris, France.Hôpital Européen Georges Pompidou, Paris, France.Hôpital Européen Georges Pompidou, Paris, France.Hôpital Européen Georges Pompidou, Paris, France.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

25614356

Citation

Bruzzi, Matthieu, et al. "Single Anastomosis or Mini-gastric Bypass: Long-term Results and Quality of Life After a 5-year Follow-up." Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery, vol. 11, no. 2, 2015, pp. 321-6.
Bruzzi M, Rau C, Voron T, et al. Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up. Surg Obes Relat Dis. 2015;11(2):321-6.
Bruzzi, M., Rau, C., Voron, T., Guenzi, M., Berger, A., & Chevallier, J. M. (2015). Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up. Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery, 11(2), 321-6. https://doi.org/10.1016/j.soard.2014.09.004
Bruzzi M, et al. Single Anastomosis or Mini-gastric Bypass: Long-term Results and Quality of Life After a 5-year Follow-up. Surg Obes Relat Dis. 2015 Mar-Apr;11(2):321-6. PubMed PMID: 25614356.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up. AU - Bruzzi,Matthieu, AU - Rau,Cédric, AU - Voron,Thibault, AU - Guenzi,Martino, AU - Berger,Anne, AU - Chevallier,Jean-Marc, Y1 - 2014/09/16/ PY - 2014/04/28/received PY - 2014/08/08/revised PY - 2014/09/03/accepted PY - 2015/1/24/entrez PY - 2015/1/24/pubmed PY - 2016/1/29/medline KW - BMI KW - Mini-gastric bypass KW - Morbid obesity KW - Quality of life KW - Weight loss SP - 321 EP - 6 JF - Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery JO - Surg Obes Relat Dis VL - 11 IS - 2 N2 - BACKGROUND: Laparoscopic mini-gastric bypass (LMGB) is an alternative to the laparoscopic Roux-en-Y gastric bypass (LRYGB), which is considered to be the gold standard in the treatment of morbid obesity. OBJECTIVES: Present 5-year results of 175 patients who had undergone a LMGB between October 2006 and October 2008. SETTING: University public hospital, France. METHODS: Complete follow-up was available in 126 of 175 patients (72%) who had LMGB. Mortality, morbidity, weight loss, co-morbidities, and quality of life were assessed. Weight loss was determined as a change in body mass index (BMI) and percent excess BMI loss (%EBMIL). Quality of life in the treatment group was analyzed using the Gastrointestinal Quality of Life Index (GIQLI) and was compared with a retrospectively case matched preoperative control group. RESULTS: There were no deaths. Thirteen patients (10.3%) developed major complications. Marginal ulcers occurred in 4% of patients. Incapacitating biliary reflux developed in 2 (1.6%) who required conversion into RYGB. Gastric pouch dilation occurred in 4 patients (3.2%) and inadequate weight loss with severe malnutrition in 2 (1.6%). At 5 years, mean BMI was 31±6 kg/m(2) and mean %EBMIL was 71.5%±26.5%. Postoperative GIQLI score of the treatment group was significantly higher than preoperative score of the control group (110.3±17.4 versus 92.5±15.9, P<.001). Social, psychological, and physical functions were increased significantly. No significant differences were found in gastroesophageal reflux or diarrhea symptoms between the 2 groups. Long-term follow-up showed an improvement in all co-morbidities. CONCLUSIONS: At 5 years, LMGB was safe, effective, and provided interesting quality of life results. SN - 1878-7533 UR - https://www.unboundmedicine.com/medline/citation/25614356/Single_anastomosis_or_mini_gastric_bypass:_long_term_results_and_quality_of_life_after_a_5_year_follow_up_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1550-7289(14)00341-4 DB - PRIME DP - Unbound Medicine ER -